MatriSys Bioscience
La Jolla
About MatriSys Bioscience
MatriSys sees commercialization paths for its intellectual property in topical dermatology therapeutics, cosmetics, and skin care. The company’s lead live biologic therapeutic is currently in Phase I/II clinical trials targeting atopic dermatitis (commonly referred to as AD or eczema) patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.5M
- Last round: Convertible Note (Mar 2021)
- Website: matrisysbio.com
- Phone: (858)456-3919
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/matrisys-bioscience-131768 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.